EPO mouse monoclonal antibody,clone OTI5D8
Applications | WB |
Reactivities | Human |
EPO mouse monoclonal antibody,clone OTI5D8
Applications | WB |
Reactivities | Human |
Epo CRISPRa kit - CRISPR gene activation of mouse erythropoietin
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
EPO CRISPRa kit - CRISPR gene activation of human erythropoietin
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
qSTAR qPCR primer pairs against Homo sapiens gene EPO
qPCR primer pairs and template standards against Homo sapiens gene EPO
Application | Plasmid of exact quantity for transcript copy number calculation |
Epo (Rat) - 3 unique 27mer siRNA duplexes - 2 nmol each
Purity | HPLC purified |
Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
qSTAR qPCR primer pairs against Mus musculus gene Epo
Transient overexpression of EPO in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
EPO - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Format | Lentiviral plasmids |
Vector | pGFP-C-shLenti |
Epo - Rat, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pRS |
EPO - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pRS |
Epo - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Format | Lentiviral plasmids |
Vector | pGFP-C-shLenti |
Epo - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Format | Retroviral plasmids |
Vector | pRS |
Rabbit anti-EPO Polyclonal Antibody
Applications | ELISA, ICC/IF, IHC, WB |
Reactivities | Human, Mouse, Rat |
热销推荐
Rabbit anti-EPO Polyclonal Antibody
Applications | ELISA, ICC/IF, IHC, WB |
Reactivities | Human, Mouse, Rat |